Nirsevimat
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nirsevimat, covering 2025-06-27 to 2025-06-27. Get the full timeline:
Most recent: Clinical Trial Update: Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination. [Phase 3]